comparemela.com
Home
Live Updates
Alzinova announces positive safety review and continuation o
Alzinova announces positive safety review and continuation o
Alzinova announces positive safety review and continuation of its Phase 1b study in Alzheimer's disease
/PRNewswire/ -- Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments for Alzheimer's disease by specifically targeting...
Related Keywords
Sweden ,
Finland ,
Stockholm ,
Swedish ,
Kristina Torfg ,
Sahlgrenska University Hospital In Gothenburg ,
Clinical Research Services Turku ,
Safety Monitoring Board ,
First In Human ,
Sahlgrenska University Hospital ,
Certified Advisor ,
Nasdaq First North Growth Market ,